American International Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-29,832
Closed -$21 3203
2020
Q4
$21 Hold
29,832
﹤0.01% 3089
2020
Q3
$67K Hold
29,832
﹤0.01% 2749
2020
Q2
$107K Hold
29,832
﹤0.01% 2500
2020
Q1
$113K Hold
29,832
﹤0.01% 2240
2019
Q4
$90K Buy
+29,832
New +$77.6K ﹤0.01% 2689

Other funds holding BMY.RT

American International Group's BMY.RT Position: Q1 2021 in Review

American International Group sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 29,832 shares — an estimated $21 sold.

American International Group first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $113K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • American International Group reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • American International Group sold 29,832 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $21.
  • American International Group first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • American International Group's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $113K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on American International Group's 13F filing for Q1 2021, filed 7 May 2021.